115 related articles for article (PubMed ID: 34312745)
1. A direct method for the identification of patterns of care using administrative databases: the case of breast cancer.
Busco S; Tavilla A; Gigli A; Lopez T; Pierannunzio D; Mallone S; Guzzinati S; Capodaglio G; Giusti F; Angiolini C; Francisci S
Eur J Health Econ; 2021 Dec; 22(9):1477-1485. PubMed ID: 34312745
[TBL] [Abstract][Full Text] [Related]
2. [A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer].
Russo A; Andreano A; Anghinoni E; Autelitano M; Bellini A; Bersani M; Bizzoco S; Cavalieri d'Oro L; Decarli A; Lucchi S; Mannino S; Panciroli E; Rognoni M; Sampietro G; Valsecchi MG; Villa M; Zocchetti C; Zucchi A
Epidemiol Prev; 2014; 38(1):16-28. PubMed ID: 24736958
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.
Will BP; Le Petit C; Berthelot JM; Tomiak EM; Verma S; Evans WK
Br J Cancer; 1999 Mar; 79(9-10):1428-36. PubMed ID: 10188886
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
7. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines.
Anderson BO; Shyyan R; Eniu A; Smith RA; Yip CH; Bese NS; Chow LW; Masood S; Ramsey SD; Carlson RW
Breast J; 2006; 12 Suppl 1():S3-15. PubMed ID: 16430397
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation.
Robertson C; Arcot Ragupathy SK; Boachie C; Dixon JM; Fraser C; Hernández R; Heys S; Jack W; Kerr GR; Lawrence G; MacLennan G; Maxwell A; McGregor J; Mowatt G; Pinder S; Ternent L; Thomas RE; Vale L; Wilson R; Zhu S; Gilbert FJ
Health Technol Assess; 2011 Sep; 15(34):v-vi, 1-322. PubMed ID: 21951942
[TBL] [Abstract][Full Text] [Related]
10. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D; Gillen E; Rixson L
JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Survival of Women with Breast Cancer. Overview Supportive Care Needs Assessment Instruments.
Ktistaki P; Alevra N; Voulgari M
Adv Exp Med Biol; 2017; 989():281-284. PubMed ID: 28971436
[TBL] [Abstract][Full Text] [Related]
12. The challenge of sustainability in healthcare systems: Frequency and cost of inappropriate patterns of breast cancer care (the E.Pic.A study).
Massa I; Balzi W; Burattini C; Gentili N; Bucchi L; Nanni O; Gallegati D; Pierini A; Amadori D; Falcini F; Altini M
Breast; 2017 Aug; 34():103-107. PubMed ID: 28558338
[TBL] [Abstract][Full Text] [Related]
13. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of case-finding algorithms for recurrence of breast cancer using routinely collected administrative data.
Xu Y; Kong S; Cheung WY; Bouchard-Fortier A; Dort JC; Quan H; Buie EM; McKinnon G; Quan ML
BMC Cancer; 2019 Mar; 19(1):210. PubMed ID: 30849954
[TBL] [Abstract][Full Text] [Related]
15. Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.
Cleary J; Ddungu H; Distelhorst SR; Ripamonti C; Rodin GM; Bushnaq MA; Clegg-Lamptey JN; Connor SR; Diwani MB; Eniu A; Harford JB; Kumar S; Rajagopal MR; Thompson B; Gralow JR; Anderson BO
Breast; 2013 Oct; 22(5):616-27. PubMed ID: 23972474
[TBL] [Abstract][Full Text] [Related]
16. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.
Ahern TP; Pedersen L; Tarp M; Cronin-Fenton DP; Garne JP; Silliman RA; Sørensen HT; Lash TL
J Natl Cancer Inst; 2011 Oct; 103(19):1461-8. PubMed ID: 21813413
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of the prevention and treatment of breast cancer--present status and open issues.
Imai H; Kuroi K; Ohsumi S; Ono M; Shimozuma K
Breast Cancer; 2007; 14(1):81-7. PubMed ID: 17245000
[TBL] [Abstract][Full Text] [Related]
18. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
